HDAC9 and cancer: In addition, some HDAC inhibitors have been found to boost the expression of receptors on cancer cells that are targets for immune cells (such as cytotoxic T lymphocytes or natural killer cells) [18–27], thereby rendering the cancer cells more liable to destruction.